[{"address1": "Gooimeer 2-35", "city": "Naarden", "zip": "1411 DC", "country": "Netherlands", "phone": "31 35 206 2971", "website": "https://www.newamsterdampharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.", "fullTimeEmployees": 68, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael Harvey Davidson FACC, Facp., M.D.", "age": 68, "title": "CEO, President & Executive Board Member", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 1122237, "exercisedValue": 0, "unexercisedValue": 51427864}, {"maxAge": 1, "name": "Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.", "age": 70, "title": "Founder, Chief Scientific Officer, Member of Executive Board & Director", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 813077, "exercisedValue": 4094829, "unexercisedValue": 35092304}, {"maxAge": 1, "name": "Mr. Mayur Amrat Somaiya", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 841238, "exercisedValue": 0, "unexercisedValue": 3954412}, {"maxAge": 1, "name": "Mr. Douglas F. Kling", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 913742, "exercisedValue": 0, "unexercisedValue": 17441960}, {"maxAge": 1, "name": "Ms. Juliette  Audet M.B.A., M.Sc.", "age": 37, "title": "Chief Strategy & Business Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 653039, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise  Kooij", "age": 48, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Philippe", "title": "Executive VP &Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bob  Rambo", "title": "Executive Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maryellen  McQuade", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marc  Ditmarsch M.D.", "age": 57, "title": "Chief Development Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 41.45, "open": 41.76, "dayLow": 40.625, "dayHigh": 41.79, "regularMarketPreviousClose": 41.45, "regularMarketOpen": 41.76, "regularMarketDayLow": 40.625, "regularMarketDayHigh": 41.79, "payoutRatio": 0.0, "beta": 0.058, "forwardPE": -21.851852, "volume": 407193, "regularMarketVolume": 407193, "averageVolume": 1126574, "averageVolume10days": 1074540, "averageDailyVolume10Day": 1074540, "bid": 41.1, "ask": 41.39, "bidSize": 2, "askSize": 1, "marketCap": 4683039744, "fiftyTwoWeekLow": 14.06, "fiftyTwoWeekHigh": 42.0, "allTimeHigh": 42.0, "allTimeLow": 5.633, "priceToSalesTrailing12Months": 132.87859, "fiftyDayAverage": 34.9564, "twoHundredDayAverage": 24.412, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3980360192, "profitMargins": 0.0, "floatShares": 57680768, "sharesOutstanding": 113390804, "sharesShort": 6817112, "sharesShortPriorMonth": 6855986, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.060100004, "heldPercentInsiders": 0.0038299998, "heldPercentInstitutions": 1.0985199, "shortRatio": 5.87, "shortPercentOfFloat": 0.0716, "impliedSharesOutstanding": 113390804, "bookValue": 6.433, "priceToBook": 6.4200215, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -221072992, "trailingEps": -2.04, "forwardEps": -1.89, "enterpriseToRevenue": 112.94, "enterpriseToEbitda": -19.635, "52WeekChange": 1.1104889, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 41.3, "targetHighPrice": 60.257572, "targetLowPrice": 30.323704, "targetMeanPrice": 46.09593, "targetMedianPrice": 45.193176, "recommendationKey": "none", "numberOfAnalystOpinions": 13, "totalCash": 702945984, "totalCashPerShare": 6.199, "ebitda": -202720000, "totalDebt": 266000, "quickRatio": 12.411, "currentRatio": 12.567, "totalRevenue": 35243000, "debtToEquity": 0.037, "revenuePerShare": 0.311, "returnOnAssets": -0.20697, "returnOnEquity": -0.39943, "grossProfits": 35243000, "freeCashflow": -69113504, "operatingCashflow": -144388992, "revenueGrowth": -0.988, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -158.45691, "financialCurrency": "USD", "symbol": "NAMS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1764362079, "regularMarketTime": 1764352801, "exchange": "NGM", "messageBoardId": "finmb_685404834", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "NewAmsterdam Pharma Company N.V.", "epsTrailingTwelveMonths": -2.04, "epsForward": -1.89, "epsCurrentYear": -1.34108, "priceEpsCurrentYear": -30.796076, "fiftyDayAverageChange": 6.3435974, "fiftyDayAverageChangePercent": 0.18147169, "twoHundredDayAverageChange": 16.887999, "twoHundredDayAverageChangePercent": 0.6917908, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-11-23", "cryptoTradeable": false, "shortName": "NewAmsterdam Pharma Company N.V", "regularMarketChangePercent": -0.361885, "regularMarketPrice": 41.3, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612881000000, "postMarketChangePercent": 1.3317173, "postMarketPrice": 41.85, "postMarketChange": 0.54999924, "regularMarketChange": -0.150002, "regularMarketDayRange": "40.625 - 41.79", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1126574, "fiftyTwoWeekLowChange": 27.239998, "fiftyTwoWeekLowChangePercent": 1.9374108, "fiftyTwoWeekRange": "14.06 - 42.0", "fiftyTwoWeekHighChange": -0.70000076, "fiftyTwoWeekHighChangePercent": -0.016666684, "fiftyTwoWeekChangePercent": 111.04889, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "isEarningsDateEstimate": true, "displayName": "NewAmsterdam Pharma Company", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]